Z-1802-2013 Class II Terminated
FDA device recall Z-1802-2013 was initiated by Becton Dickinson & Co. on Jun 6, 2013 and is designated Class II. Reason for recall: Microbiological identification media may exhibit reduced levels of Vancomycin. The recall status is terminated (terminated Sep 3, 2013). Affected quantity: 42 cartons.
Recall Details
- Product Type
- Devices
- Report Date
- Jul 31, 2013
- Initiation Date
- Jun 6, 2013
- Termination Date
- Sep 3, 2013
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 42 cartons
Product Description
BD BBL BBE // CDC Anaerobe Laked Sheep Blood Agar with KV, packaged in cartons of 100 plates, Catalog # 297260, and labeled in part ***Becton, Dickinson and Company 7 Loveton Circle Sparks, MD 21152 USA 800-638-8663 www.bd.com/ds*** Bacteroides Bile Esculin Agar (BBE) is recommended as a primary isolation medium for the selection and presumptive identification of the B. fragilis group.
Reason for Recall
Microbiological identification media may exhibit reduced levels of Vancomycin.
Distribution Pattern
Worldwide distribution: US (nationwide) and countries of:Belgium, Canada, Columbia, Mexico, Singapore, and Taiwan.
Code Information
Lot 3071112 Exp 5/28/13
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-1802-2013
- openFDA file date
- Oct 23, 2026
- Loaded by RegDataLab
- Oct 25, 2026